Progression from productive infection to integration and oncogenic transformation in human papillomavirus type 59-immortalized foreskin keratinocytes

Virology

Volumn 336, Issue 1, 2005, Pages 11-25

  Spartz, Helena ^a   Lehr, Elizabeth ^a   Zhang, Benyue ^a,b,c   Roman, Ann ^a,b,c   Brown, Darron R ^a,d  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WALTHER CANCER INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

ERIN 59; Human papillomavirus; Keratinocyte

Indexed keywords

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL LINE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; EPISOME; ERIN 59 CELL; GENE EXPRESSION; GENE NUMBER; HOST CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMA VIRUS TYPE 59; KERATINOCYTE; MALIGNANT TRANSFORMATION; NUCLEOTIDE SEQUENCE; ONCOGENE; OPEN READING FRAME; PREPUCE; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TUMOR PROMOTION; VIRUS GENOME; VIRUS INFECTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 59;

EID: 18044365191     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.02.026     Document Type: Article

References (59)

1. S.A. Aaronson Growth factors and cancer Science 254 1991 1146 1153
2. 1 Cancer Res. 62 2002 6959 6965
3. E. Auvinen, S. Hietanen, L. Gissmann, and A. Alonso Human papillomavirus type 33 DNA and E6-E7 transcripts in late passages of the UT-DEC-1 vaginal keratinocyte cell line Mol. Cell. Probes 12 1 1998 59 62
4. G. Badaracco, A. Venuit, A. Sedati, and M.L. Marcante HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness J. Med. Virol. 67 2002 574 582
5. L. Barzon, S. Pizzighella, L. Corti, C. Mengoli, and G. Palu Vaginal dysplastic lesions in women with hysterectomy and receiving radiotherapy are linked to high-risk human papillomavirus J. Med. Virol. 67 2002 401 405
6. V. Bechtold, P. Beard, and K. Raj Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA J. Virol. 77 3 2003 2021 2028
7. B.A. Bernard, C. Bailly, M.-C. Lenoir, M. Darmon, F. Thierry, and M. Yaniv The human papillomavirus type 18 (HPV 18) E2 gene product is a repressor of the HPV 18 regulatory region in human keratinocytes J. Virol. 63 1989 4317 4324
8. A.L. Bezerra, A. Lopes, G. Landman, G.N. Alencar, H. Torloni, and L.L. Villa Clinicopathologic features and human papillomavirus DNA prevalence of warty and squamous cell carcinoma of the penis Am. J. Surg. Pathol. 25 2001 673 678
9. J.T. Bryan, J. Tekchandani, J.M. Schroeder, and D.R. Brown Propagation of human papillomavirus type 59 in the athymic mouse xenograft system Intervirology 43 2 2000 112 118
10. K. Cooper, C.S. Herrington, J.E. Stickland, M.F. Evans, and J.O.D. McGee Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridisation J. Clin. Pathol. 44 12 1991 990 996
11. J.R. Daling, M.M. Madeleine, S.M. Schwartz, K.A. Shera, J.J. Carter, B. McKnight, P.L. Porter, D.A. Galloway, J.K. McDougall, and H. Tamimi A population-based study of squamous cell vaginal cancer: HPV and cofactors Gynecol. Oncol. 84 2002 263 270
12. B.C. Das, J.K. Sharma, V. Gopalakrishna, and U.K. Luthra Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions J. Gen. Virol. 73 1992 2327 2336
13. K. De Geest, M.E. Turyk, M.I. Hosken, J.B. Hudson, L.A. Laimins, and G.D. Wilbanks Growth and differentiation of human papillomavirus type 31b positive human cervical cancer cell lines Gynecol. Oncol. 49 1993 303 310
14. C. Demeret, C. Desaintes, M. Yaniv, and F. Thierry Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes J. Virol. 71 12 1997 9343 9349
15. J. Dillner, G. von Krogh, S. Horenblas, and C. Meijer Etiology of squamous cell carcinoma of the penis Scand. J. Urol. Nephrol., Suppl. 205 2000 189 193
16. J.J. Dowhanick, A.A. McBride, and P.M. Howley Suppression of cellular proliferation by the papillomavirus E2 protein J. Virol. 69 12 1995 7791 7799
17. M.K. El Awady, J.B. Kaplan, S.J. O'Brien, and R.D. Burk Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa Virology 159 1987 389 398
18. M.F. Evans, and K. Cooper Human papillomavirus integration: detection by in situ hybridization and potential clinical application J. Pathol. 202 2004 1 4
19. M.F. Evans, S.L. Mount, B.G. Beatty, and K. Cooper Biotinyl-tyramide- based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia Mod. Path. 15 2002 1339 1347
20. R.N. Fichorova, J.G. Rheinwald, and D.J. Anderson Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins Biol. Reprod. 57 4 1997 847 855
21. E.R. Flores, and P.F. Lambert Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle J. Virol. 71 10 1997 7167 7179
22. E.R. Flores, B.L. AllenHoffmann, D. Lee, C.A. Sattler, and P.F. Lambert Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line Virology 262 2 1999 344 354
23. E. Gillitzer, G. Chen, and A. Stenlund Separate domains in E1 and E2 proteins serve architectural and productive roles for cooperative DNA binding EMBO J. 19 12 2000 3069 3079
24. G. Gross, and H. Pfister Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts Med. Microbiol. Immunol. 193 2004 35 44
25. M. Herlyn, R. Kath, N. Williams, I. Valyi-Nagy, and U. Rodeck Growth-regulatory factors for normal, premalignant, and malignant human cells in vitro Adv. Cancer Res. 54 1990 213 234
26. Z. Hernadi, T. Sapy, and Z.T. Krasznai The prevalence of the HPV 16 genome, integrated viral status and p53 genotype in cervical cancer population of north-eastern Hungary, the correlation with the established markers of tumour progression Eur. J. Obstet. Gynecol. Reprod. Biol. 113 2004 83 86
27. S. Hietanen, E. Auvinen, S. Grenman, T. Lakkala, A. Sajantila, P. Klemi, and J. Maenpaa Isolation of 2 keratinocyte cell lines derived from HPV-positive dysplastic vaginal lesions Int. J. Cancer 52 3 1992 391 398
28. A.H. Hopman, F. Smedts, W. Dignef, M. Ummelen, G. Sonke, M. Mravunac, G.P. Vooijs, E.J. Speel, and F.C. Ramaekers Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities J. Pathol. 202 2004 23 33
29. G. Hudelist, M. Manavi, K.I. Pischinger, T. Watkins-Riedel, C.F. Singer, E. Kubista, and K.F. Czerwenka Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade Gynecol. Oncol. 92 2004 873 880
30. M. Hummel, J.B. Hudson, and L.A. Laimins Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes J. Virol. 66 1992 6070 6080
31. S. Jeon, and P.F. Lambert Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis Proc. Natl. Acad. Sci. U.S.A. 92 5 1995 1654 1658
32. S. Jeon, B.L. Allen-Hoffmann, and P.F. Lambert Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells J. Virol. 69 5 1995 2989 2997
33. H.M. Kerstens, P.J. Poddighe, and A.G. Hanselarr A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine J. Histochem. Cytochem. 43 1995 347 352
34. R. Klaes, S.M. Woerner, R. Ridder, N. Wentzensen, M. Duerst, A. Schneider, B. Lotz, P. Melsheimer, and M.V. Doeberitz Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes Cancer Res. 59 24 1999 6132 6136
35. L. Koutsky Epidemiology of genital human papillomavirus infection Am. J. Med. 102 5A 1997 3 8
36. P.A. Lazo Structure, DNaseI hypersensitivity and expression of integrated papilloma virus in the genome of HeLa cells Eur. J. Biochem. 165 1987 393 401
37. E.E. Lehr, B. Qadadri, C. Brown, and D.R. Brown Human papillomavirus type 59 immortalized keratinocytes express late viral proteins and infectious virus after calcium stimulation Virology 314 2003 562 571
38. G. Lizard, P. Roignot, P. BrunetLecomte, and Y. Chardonnet Morphological analysis of in situ hybridization signals in cervical intraepithelial neoplasia containing human papillomavirus type 16 or 18: relationship with histological grade and DNA content Cytometry 34 4 1998 180 186
39. S. Logani, D. Lu, W.G. Quint, L.H. Ellenson, and E.C. Pirog Low-grade vulvar and vaginal intraepithelial neoplasia: correlation of histologic features with human papillomavirus DNA detection and MIB-1 immunostaining Mod. Path. 16 2003 735 741
40. A.A. McBride, and P.M. Howley Bovine papillomavirus with a mutation in the E2 serine 301 phosphorylation site replicates at a high copy number J. Virol. 65 1991 6528 6534
41. A. Nishimura, T. Ono, A. Ishimoto, J.J. Dowhanick, M.A. Frizzell, P.M. Howley, and H. Sakai Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition J. Virol. 74 8 2000 3752 3760
42. M. Ozbun Human papillomavirus type 31b infection of human keratinocytes and the onset of early transcription J. Virol. 76 22 2002 11291 11300
43. M.A. Ozbun, and C. Meyers Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b J. Virol. 71 7 1997 5161 5172
44. P. Peitsaro, S. Hietanen, B. Johansson, T. Lakkala, and S. Syrjanen Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage Carcinogenesis 23 2002 1057 1064
45. M.R. Pett, W.O. Alazawi, I. Roberts, S. Dowen, D.I. Smith, M.A. Stanley, and N. Coleman Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes Cancer Res. 64 2004 1359 1368
46. J. Rho, A. Roy-Burman, H. Kim, E.M. de Villiers, T. Matsukura, and J. Choe Nucleotide sequence and phylogenetic classification of human papillomavirus type 59 Virology 203 1 1994 158 161
47. J. Rho, E.M. deVilliers, and J. Choe Transforming activities of human papillomavirus type 59 E5, E6 and E7 open reading frames in mouse C127 cells Virus Res. 44 1 1996 57 65
48. S.J. Robboy, M.C. Anderson, and P. Russell Pathology of the Female Reproductive Tract 2002 Churchill Livingstone London
49. H. Romanczuk, and P.M. Howley Disruption of either the E1 or E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity Proc. Natl. Acad. Sci. U.S.A. 89 1992 3159 3163
50. T. Sano, T. Hikino, Y. Niwa, K. Kashiwabara, T. Oyama, T. Fukuda, and T. Nakajima In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions Mod. Path. 11 1 1998 19 23
51. M.H. Schiffman, and L.A. Brinton The epidemiology of cervical carcinogenesis Cancer 76 Suppl. 10 1995 1888 1901
52. M.H. Schiffman, and R.D. Burk Human papillomaviruses A.S. Evans R.A. Kaslow Viral Infections of Humans 1997 Plenum Medical Book Company New York 983 1022
53. M.A. Stanley, H.M. Browne, M. Apeleby, and A.C. Minson Properties of a non-tumorigenic human cervical keratinocyte cell line Int. J. Cancer 43 1989 672 676
54. J. Sterling, M. Stanley, G. Gatward, and T. Minson Production of human papillomavirus type 16 virions in a keratinocyte cell line J. Virol. 64 1990 6305 6307
55. J.C. Sterling, J.N. Skepper, and M.A. Stanley Immunoelectron microscopical localization of human papillomavirus type 16 L1 proteins and E4 proteins in cervical keratinocytes cultured in vivo J. Invest. Dermatol. 100 2 1993 154 158
56. M. Stupar The presence of human papillomavirus-16 genome in the CaSki cervical carcinoma DNA Iugosl. Physiol. Pharmacol. Acta 25 1989 45 52
57. F. Thierry, and P.M. Howley Functional analysis of E2-mediated repression of the HPV 18 P105 promoter New Biol. 3 1991 90 100
58. M. van Beurden, F.W. ten Kate, S.P. Tjong-A-Hung, A.J. de Craen, N. van der Vange, F.B. Lammes, and J. ter Schegget Human papillomavirus DNA in multicentric vulvar intraepithelial neoplasia Int. J. Gynecol. Pathol. 17 1998 12 16
59. H. zur Hausen Human papillomaviruses in the pathogenesis of anogenital cancer Virology 184 1991 9 13